Considerable Gaps Seen in Provision of Effective Treatment for Opioid Addiction
By Elana Gotkine HealthDay Reporter
TUESDAY, July 16, 2024 -- There are considerable gaps in provision of effective treatments for opioid use disorders (OUD) at U.S. substance use disorder (SUD) treatment facilities, according to a study published online July 11 in the Journal of the American Medical Association.
Tae Woo Park, M.D., from the University of Pittsburgh, and colleagues conducted a cross-sectional study of specialty outpatient SUD treatment facilities that treat OUD. The prevalence of available treatments individually and combined was reported. Treatments offered in federally certified opioid treatment program (OTP) and non-OTP facilities were compared.
Overall, 17,353 representatives from SUD facilities were surveyed. OUD treatment was offered at 12,060 outpatient facilities: 1,925 and 10,135 OTPs and non-OTPs, respectively. The researchers found that 99.4 and 55.1 percent of OTP and non-OTP facilities offered medications for OUD (MOUD), respectively, and 35.2 percent of facilities offered psychosocial treatments only. Of the facilities that offered MOUD, a higher proportion of OTPs versus non-OTPs offered any MOUD plus contingency management (53.3 versus 41.6 percent), and a lower proportion of OTPs offered any MOUD, any psychosocial treatment, other SUD treatment, and mental health services (16.7 versus 33.5 percent). Overall, 62.2, 45.6, and 2.0 percent of facilities offered at least one, at least two, and all four MOUD types, respectively. A lower proportion of non-OTPs offered sublingual and injectable buprenorphine compared with OTPs (49.7 versus 83.4 percent; 22.4 versus 26.4 percent); injectable naltrexone was offered at similar rates. OTPs offered contingency management more frequently than non-OTPs (54.1 versus 40.2 percent).
"Substance use treatment facilities reported significant gaps in provision of effective treatments for OUD," the authors write.
One author reported ties to relevant organizations.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Half of Youth-Serving Clinicians Screen for Substance Use Disorder at Every Well Visit
THURSDAY, May 22, 2025 -- Just over half of youth-serving clinicians report that they routinely screen adolescents for substance use disorders (SUDs) at every well visit...
Previous Estimates of Illicit Opioid Use in the United States Underreported
WEDNESDAY, May 14, 2025 -- Illicit opioid use may be higher than previously reported in the United States, according to a study published online May 9 in JAMA Health...
Rates of Fentanyl Nonfatal Overdose ED Visits Rose Through Third Quarter of 2023
WEDNESDAY, May 14, 2025 -- From 2020 to 2023, there was an increase in the rates of fentanyl-involved nonfatal overdose emergency department visits, according to research...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.